Several registry-based randomised clinical trials supported by UCR were presented and discussed at the European Society of Cardiology meeting in late August (ESC Congress 2017). Examples are:

Oxygen therapy does not improve survival in patients with heart attack symptoms (DETO2X-AMI)
Latest Bivalirudin, Heparin face-off in MI cements winner in routine practice (VALIDATE- SWEDEHEART)

Another trial was presented at the American College of Cardiology ACC.17: 66th Annual Scientific Session & Expo in March:
iFR-guided strategy delivers consistent patient outcomes to an FFR-guided strategy (iFR-SWEDEHEART)

These studies are published in the New England Journal of Medicine:

UCR is proud to contribute to increased health in Sweden and the rest of the world.

Back to top